NORGESNAPRAPATENE AS
Aksjeselskap (AS) · Oslo, Norway · LEI 6367002JX7XYMX3KWN75
LEI active
Summary
NORGESNAPRAPATENE AS is registered in Norway and entered in the “Register of Business Enterprises (Foretaksregisteret)” under number 831 011 742. Its legal form is Aksjeselskap (AS) – limited company (Norway). According to GLEIF, its ultimate parent is MITTET INVEST AS (Norway), which is also its direct parent. That group has 1 subsidiary with LEIs in 1 country, 1 of them in Norway. The LEI was first issued on 28 Feb 2024 and the record was last updated on 2 Jan 2026; the next renewal is due by 28 Feb 2027.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | Aksjeselskap (AS) limited company (Norway) |
|---|---|
| Register | Register of Business Enterprises (Foretaksregisteret) · Register website |
| Registration number | 831 011 742 |
| Registration authority | The Brønnøysund Register Centre |
| Jurisdiction | Norway |
| Registered address | Øvre Slottsgate 6, 0157 Oslo, Norway |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 16 Feb 2023 |
| LEI | 6367002JX7XYMX3KWN75 |
| LEI status | active |
| LEI first issued | 28 Feb 2024 |
| LEI record last updated | 2 Jan 2026 |
| Next LEI renewal | 28 Feb 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
NORGESNAPRAPATENE AS this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | MITTET INVEST AS | MITTET INVEST AS |
| Accounting period | 31 Dec 2024 to 30 Dec 2025 | 31 Dec 2024 to 30 Dec 2025 |
| Evidence | supporting documents | supporting documents |
| Corroboration | partly corroborated | partly corroborated |
| Relationship start | 6 Feb 2025 | 6 Feb 2025 |
| Recorded at GLEIF since | 6 Feb 2025 | 6 Feb 2025 |
| Last updated | 2 Jan 2026 | 2 Jan 2026 |
| Record status | current | current |